Publications

Evaluation of TrpM and PsiD Substate Promiscuity Reveals New Biocatalytic Capabilities

Kanis F., Broude C., Hellwarth E. B., Gibbons E. J., Sen A. K., Adams A. M., Wang X., Jones J. A. (2024) Biotechnology Progress. e3492.

Effect of Oral Tryptamines on the Gut Microbiome of Rats – A Preliminary Study

Xu M., Kiss A. J., Jones J. A., McMurray M. S., Shi H. (2024) PeerJ. 12:e17517

Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms

Rakoczy R. J., Runge G. N., Sen A. K., Sandoval O., Nguyen Q., Roberts B. R., Sciortino J. H., Gibbons W. J., Friedberg L. M., Jones J. A., McMurray M. S. (2024) British Journal of Pharmacology. 1-15.

Simultaneous glucose and xylose utilization by an E. coli catabolite repression mutant

Kaplan N. A., Islam K. N., Kanis F. C., Verderber J., Wang X., Jones J. A., Koffas M. A. G. (2023) Applied and Environmental Microbiology. 90(2), e02168-23.

Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli

*Flower J. E., *Gibbons W. J., Adams A. M., Wang X., Broude C. N., Jones J. A. (2023) Biotechnology and Bioengineering. 120:2214-2229.

In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli

Friedberg L. M., Sen A. K, Nguyen Q., †Tonucci G., Hellwarth E. B., Gibbons W. J., Jones J. A. (2023) Metabolic Engineering. 78, 61-71.

Effect of Psilocybin on Decision-Making and Motivation in the Healthy Rat

Roberts B. F., Zylko A. L., Waters C. E., Crowder J. D., Gibbons W. J., Sen A. K., Jones J. A., McMurray M. S. (2022) Behavioural Brain Research, 440, 114262.

Harnessing synthetic biology to develop novel psychedelic therapies

Jones J. A., Spigarelli M. G. (2022) Industry Highlight. Trends in Biotechnology. 41, 586-587.

Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats

Adams A. M., Anas N. A., Sen A. K., Hinegardner-Hendricks J. D., O’Dell P. J., Gibbons W. J., Flower J. E., McMurray M., Jones J. A. (2022) Metabolic Engineering Communications, 14, e00196.

Unlocking the Biosynthesis of Psychedelic-Inspired Indolethylamines

Sen A. K., Jones J. A. (2023) Spotlight Article. Trends in Biochemical Sciences. 49(3), 189-191.

Thermodynamics contributes to high terpene productivity in cyanobacteria

Shinde S., Singapuri S., Jiang Z., Long B., Wilcox D., Klatt C., Jones J. A., Yuan J. S., Wang X. (2022) Metabolic Engineering Communications, 14, e00193.

De novo biosynthesis of salvianolic acid B in Saccharomyces cerevisiae engineered with rosmarinic acid biosynthesis pathway

*Xu Y., *Geng L., *Zhang Y., Jones J. A., Zhang M., Chen Y., Tan R., Koffas M. A. G., Wang Z., Zhao S. (2022) Journal of Agricultural and Food Chemistry. 70(7), 2290-2302

Homebrewed Psilocybin: Can New Routes for Pharmaceutical Psilocybin Production Enable Recreational Use?

*Gibbons W., *O’Dell P., *Bollinger B., *McKinney M., Jones J. A. (2021) Bioengineered. 12(1), 8863-8871.

The three NADH dehydrogenases of Pseudomonas aeruginosa: their roles in energy metabolism and links to virulence

Hreha T. N., Foreman S., Duran-Pinedo A., Morris A. R., Diaz-Rodrigues P., Jones J. A., Ferrara K., Bourges A., Rodriguez L., Koffas M. A. G., Hahn M., Houser A., Barquera B. (2020) PLOS ONE. 16(2), e0244142.

In vivo production of psilocybin in E. coli

Adams A. M., Kaplan N. A., Wei Z., Brinton J. D., Monnier C. S., Enacopol A. L., Ramelot T. A., Jones J. A. (2019) Metabolic Engineering. 56, 111-119.

Use of bacterial co-cultures for the efficient production of chemicals

Jones J. A., Wang X. (2018) Current Opinion in Biotechnology. 53, 33-38.